e-ISSN: Pending
Negative / Null Result ReportOpen accessMedicine· cited by 17

Liver exerkine reverses aging- and Alzheimer’s-related memory loss via vasculature

Gregor Bieri; Karishma J.B. Pratt; Yasuhiro Fuseya; Turan Aghayev; Juliana Sucharov; Alana Horowitz; Amber R. Philp; Karla Fonseca-Valencia · 2026 · Cell

WASTE classifies this as Negative / Null Result Report · AI classification, approximate

The study found no significant effect — useful as a negative control or null benchmark for your own design.

Abstract

Blood factors transfer the benefits of exercise to the aged brain independent of physical activity. Here, we show that the liver-derived exercise factor (exerkine) glycosylphosphatidylinositol (GPI)-specific phospholipase D1 (GPLD1), a GPI-degrading enzyme, reverses aging- and Alzheimer's-related memory loss by targeting the brain vasculature. GPLD1 has the potential to cleave over 100 putative GPI-anchored proteins, necessitating the identification of downstream targets that mediate cognitive rejuvenation for translational application. We identified GPI-anchored tissue-nonspecific alkaline ph

Abstract by Gregor Bieri; Karishma J.B. Pratt; Yasuhiro Fuseya; Turan Aghayev; Juliana Sucharov; Alana Horowitz; Amber R. Philp; Karla Fonseca-Valencia, Cell (2026) — licensed CC BY 4.0.

About to run something similar?

Run an AI Precheck on your own design to catch failure modes like this one before you spend the time. Your first desk check is free.

WASTE indexes this work — it does not host or republish it. Failure-type classification is automated and approximate.

Metadata source: OpenAlex · DOI 10.1016/j.cell.2026.01.024